Saritaben Vallabhbhai Savani

Par Drugs And Chemicals Limited

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 1 buy · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€4,257

▼ Sales (2 ops.)

€246k

Latest filing published 04 Dec 2025 for Par Drugs And Chemicals Limited, €4,257.

Filing timeline

BuySale

Saritaben Vallabhbhai Savani

Saritaben Vallabhbhai Savani: trading record in brief

Saritaben Vallabhbhai Savani appears in our data through filings on Par Drugs And Chemicals Limited shares, published by SEBI (PIT + SAST). In total, 4 filings cover trades dated from 21 June 2022 to 3 December 2025.

Market trades split into 1 purchase (€4,257) and 2 sales (€246k). On balance, insiders were net sellers of €242k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2025: 1 purchase and no sales on the market.

The record was last updated on 4 December 2025 with an open-market purchase (€4,257) in Par Drugs And Chemicals Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.